pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

Congress must restore independence of scientific advisory panels after controversial firings

Oct 30, 2026·read at STAT ↗RegulatoryNegative

The authors note the recent dismissal of two vice chairs of the U.S. Preventive Services Task Force by HHS Secretary Robert F. Kennedy Jr., stressing the panel’s role in reviewing evidence to guide coverage of services such as cancer screening.

They remind readers that Congress created the task force under the Affordable Care Act with a legal requirement for expert staffing and protection from political pressure, and argue the firings violate that mandate.

The piece places the action in a larger trend of dismantling scientific advisory bodies, referencing the Trump administration’s termination of 151 committees in 2025, and warns that continued erosion could degrade health‑policy decisions.

The authors urge Congress to pass reforms that guarantee advisory committees are populated by qualified experts and shielded from political interference, restoring credibility to the advisory process.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: How Congress can fix expert advisory committees”

read at STAT ↗
1,113 words · retrieved 16m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1h agoSTAT+: How a simple UTI turns into a $1,756 billSTAT
  • 1h agoThe health care issues STAT reporters are watching in the midtermsSTAT
  • 1h agoSTAT+: FDA, CMS scramble to avoid regulatory logjam as more states look to test AI in clinical settingsSTAT
  • 1h agoOpinion: What a mother’s 1834 letter about measles tells us about MAHASTAT
  • 14h agoSTAT+: Federal judge rejects new Medicaid ‘frailty’ definition for work requirementsSTAT